MedTrace Logo

To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases

NCT03845348 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2022-10-26

No results posted yet for this study

Summary

Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful rate reaching nearly 95%. This trial is going to evaluate the efficacy of getting rid of dandruff as well as the safety of the investigational products in comparison to a reference (ketoconazole 2%) during a 4-week treatment period.

Conditions

  • Scalp Dermatitis

Interventions

OTHER

TD03

Shampoo TD 3 days

OTHER

TD07

Shampoo TD 7 days

DRUG

Ketoconazole 2% Shampoo

Ketoconazole 2% Shampoo

Sponsors & Collaborators

  • Big Leap Research

    collaborator OTHER

  • Sao Thai Duong Joint Stock Company

    lead INDUSTRY

Principal Investigators

  • Phuong TM Pham · National Hospital of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-22
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845348 on ClinicalTrials.gov